ArticleBMJ open2025

Renin-guided therapy with mineralocorticoid receptor antagonists in primary aldosteronism: feasibility study (RETAME-PA) - a clinical research protocol for a randomised controlled trial.

Amel Merabtine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.